Empowering Patients: The 5‑Question Melanoma Diagnostic Checklist

📋 Download the checklist here:
https://www.geneseq.com.au/about-melaseq/melanoma-misdiagnosis-risks-realities/

#MelanomaAwareness #SkinHealth #PatientEmpowerment #EarlyDetection #DiagnosticExcellence #Pathology

Kerri, 35, had a mole her GP dismissed, but it later itched and bled. Its removal showed melanoma. She urges trusting instincts and seeking second opinions, as GPs correctly diagnose melanomas just 29% of the time. #SkinCheck #MelanomaAwareness #TrustYourInstincts #EarlyDetectionMatters

🩺 One Biopsy, Three Opinions, One Decision. Dr. Julia Marks got opinions from benign to melanoma. She asked, "Another opinion?", "Sub-specialist?", "Genomic tools?" With expert advice, she chose conservative treatment and is healthy. ✅

Genomic profiling helps assess melanoma risk by analyzing microRNA expressions in lesions. Researchers create a scoring system for malignancy by identifying microRNA signatures, aiming to standardize diagnostics. #MelanomaAwareness #GenomicTesting #SkinHealth

MicroRNAs influence gene activity and their disruption in melanoma aids cancer growth. This forms a molecular fingerprint separating melanoma from benign moles. Tracking these changes can enable earlier, precise diagnoses. #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine

Genetic markers in moles unveil melanoma insights. Small molecules show severity; genomic tech detects RNA shifts, aiding early cancer detection. Result? Greater accuracy in diagnosis with 'molecular profiles.' #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine

Diagnosing moles is tricky; misdiagnoses can cause anxiety or wrong treatment. Learn why it's complex and discover new tools.

Empower your health!

#MelanomaAwareness #DiagnosisMatters #KnowYourSkin

Melanoma diagnosis varies greatly, showing tech limits. A 2017 study had only 25% agreement on atypical moles and 43% for early melanomas. Consider second opinions and stay informed on diagnostic tools for "early" or borderline lesions.

#Dermatology #MelanomaDiagnosis #Pathology #PatientSafety

Diagnosing moles is tricky. Early melanoma diagnoses often vary, risking misdiagnoses. This may cause false reassurances or unnecessary surgeries. Researchers aim to improve detection. #MelanomaAwareness #DiagnosisMatters #KnowYourSkin

Diagnosing moles is complex! Many early melanomas are misdiagnosed, leading to errors in treatment. We urgently need better detection tools. Join us this month to explore advancements in melanoma diagnosis.

#MelanomaAwareness #DiagnosisMatters #KnowYourSkin

Great response from the media to our announcement this week. Melaseq is the first diagnostic test for melanoma that was entirely designed, validated and approved in Australia! 🇦🇺 ☀️ 🧪

Australia’s first multi gene test to help diagnose melanoma early and accurately. #melaseq 🧪